Literature DB >> 10526197

Migratory basal ganglia lesions in subacute sclerosing panencephalitis (SSPE): clinical implications of axonal spread.

Y Sawaishi1, T Yano, Y Watanabe, G Takada.   

Abstract

We report a boy with subacute sclerosing panencephalitis (SSPE) who exhibited parkinsonian symptoms four months after onset. The symptoms improved after administration of levodopa. One year after onset, bilateral symmetric lesions appeared in the substantia nigra and the putamen, as observed using magnetic resonance imaging. After a one-year interval, the lesions migrated to the bilateral caudate and the cerebellar dentate nuclei. The series of migratory legions, each of which was connected by axonal pathways originating from the substantia nigra, suggests axonal spread of the SSPE virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526197     DOI: 10.1016/s0022-510x(99)00177-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

Review 1.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

2.  An evaluation of subacute sclerosing panencephalitis patients with diffusion-weighted magnetic resonance imaging.

Authors:  M Abuhandan; H Cece; M Calik; E Karakas; F Dogan; O Karakas
Journal:  Clin Neuroradiol       Date:  2012-08-12       Impact factor: 3.649

3.  Evolution of certain typical and atypical features in a case of subacute sclerosing panencephalitis.

Authors:  Tushar Premraj Raut; Maneesh Kumar Singh; Ravindra Kumar Garg; Dheeraj Rai
Journal:  BMJ Case Rep       Date:  2012-12-23

4.  Subacute Sclerosing Panencephalitis Causing Rapidly Progressive Dementia and Myoclonic Jerks in a Sexagenarian Woman.

Authors:  Antonio Jose Reyes; Kanterpersad Ramcharan; Sean Perot; Stanley Lawrence Giddings; Fidel Rampersad; Reanna Gobin
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.